Amicus Therapeutics Inc

Amicus Therapeutics Inc (FOLD) Price Prediction & Forecast

$14.490

+0.030 (+0.21%)At close

Price Predictions

1-Day Price Prediction
+0.15%
1-Week Prediction
+3.29%
1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

FOLD Prediction & Forecast by Similar Chart Analysis

Alphio's FOLD stock price prediction model matches the current Amicus Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.51 (+0.15%). The 1-week path is $14.97 (+3.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Amicus Therapeutics Inc Stock?

Amicus Therapeutics Inc (FOLD) is not a strong buy for a long-term beginner investor at this time. While the stock shows some bullish moving averages and stable technical indicators, the lack of significant positive catalysts, weak financial performance in the latest quarter, and neutral trading sentiment suggest that this is not an ideal entry point. Additionally, the absence of recent AI Stock Picker or SwingMax signals further reduces the attractiveness of this stock for immediate investment.

FOLD stock price ended at $14.49 on Friday, after rising +0.21%

Amicus Therapeutics Inc (FOLD) last closed at $14.49, gaining +0.21%. These facts feed the 1-day and 1-week FOLD price prediction above.

Analyst Consensus

Amicus Therapeutics Inc (FOLD): 6 buy, 1 hold, 0 sell. Outlook: Strong Buy.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Strong buy
Sell
0
Buy
6

Forecast Drivers

Amicus Therapeutics Inc (FOLD) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Negative

Bearish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches FOLD, ranked by similarity.

Seasonality analysis for FOLD

Historically the probability of a positive August return for FOLD is 0.00%. February offers the highest probability of a positive month at 55.17%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for FOLD

MonthMin PriceAvg PriceMax PricePotential ROI
Aug 2026$7.44$8.05$9.41-44.42%
Sep 2026$6.71$7.97$8.55-44.97%
Oct 2026$6.80$7.90$9.10-45.45%
Nov 2026$4.97$6.60$6.65-54.44%
Dec 2026$7.93$8.81$10.50-39.19%

In 2026, Amicus Therapeutics Inc (FOLD) is projected to range from $4.97 to $10.50.

Amicus Therapeutics Inc 2026 monthly forecast

Aug 2026 FOLD forecast
Potential ROI: -44.42%

In Aug 2026, Amicus Therapeutics Inc is projected to average $8.05, with a low of $7.44 and high of $9.41.

Sep 2026 FOLD forecast
Potential ROI: -44.97%

In Sep 2026, Amicus Therapeutics Inc is projected to average $7.97, with a low of $6.71 and high of $8.55.

Oct 2026 FOLD forecast
Potential ROI: -45.45%

In Oct 2026, Amicus Therapeutics Inc is projected to average $7.90, with a low of $6.80 and high of $9.10.

Nov 2026 FOLD forecast
Potential ROI: -54.44%

In Nov 2026, Amicus Therapeutics Inc is projected to average $6.60, with a low of $4.97 and high of $6.65.

Dec 2026 FOLD forecast
Potential ROI: -39.19%

In Dec 2026, Amicus Therapeutics Inc is projected to average $8.81, with a low of $7.93 and high of $10.50.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started